MHR Restructures Lionsgate Stake, Grants Lead Investor Board and Liquidity Rights

summarizeSummary

MHR restructured its Lionsgate Studios stake through new continuation vehicles, bringing in lead investor RenWave Kore. The deal grants RenWave board designation rights and liquidity protections, including a forced sale mechanism if return targets aren't met.

check_boxKey Events · Ownership and Investor Activity · LION

• MHR Completes Internal Restructuring

  On July 8, 2026, MHR consummated the CV Transaction, transferring Lionsgate Common Shares from legacy funds to newly formed continuation vehicles (MHR LION Holdco A/B, SubHoldco A/B). As a result, Institutional Partners III and Institutional Advisors III ceased to be 5% beneficial owners.

• Lead Investor Gains Board Designation Right

  RenWave Kore, the lead investor, can designate one independent director to Lionsgate's board, subject to MHR's right to designate three directors and Lionsgate's governance processes. This right activates 90 days before the first post-closing shareholder meeting.

• Liquidity Protections for Lead Investor

  If the Minimum Liquidity Threshold—defined as 125% of invested capital returned—is not met by five years plus three months, RenWave can force the SubHoldCos to transfer Lionsgate shares to meet the shortfall. Additionally, a Wind Down Right allows RenWave to force liquidation or distribution in kind if assets remain unrealized six months after the fund term expires.

• No Immediate Dilution or Share Sales

  The restructuring is an internal transfer among MHR-controlled entities. No new shares were issued, and no public market sales occurred. Dr. Rachesky's reported beneficial ownership remains approximately 13.0%, representing 37.9 million shares.

auto_awesomeAnalysis · LION · Trade & Services

On July 8, 2026, MHR Fund Management—controlled by Mark Rachesky—completed an internal reorganization of its Lionsgate Studios holdings. The restructuring shifted shares from legacy funds into new continuation vehicles, backed by lead investor RenWave Kore. As part of the deal, RenWave secured the right to designate one independent director to Lionsgate's board and obtained liquidity protections, including a mechanism to force share sales if a minimum return threshold isn't met within five years. While no shares were sold to the public, the new governance rights and potential future overhang from forced sales could influence board dynamics and long-term shareholder alignment.